Cancer Drug News Do certain diabetes drugs increase the risk of acute kidney injury in patients taking anti-cancer therapies?
Protected: Tecartus® (Brexucabtagene Autoleucel) CAR T-cell therapy now funded in Australia for adult relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r ALL)
Cancer Drug News Donors key to discovery of potential new combination therapy for leukaemia April 20, 2021 With the generous support of donors, WEHI researchers have discovered why some leukaemia cells are…
AACR AACR 2021: Neoadjuvant nivolumab plus chemotherapy increased pathological complete response rate in CheckMate-816 lung cancer trial April 15, 2021 Adding nivolumab to chemotherapy as neoadjuvant treatment for patients with resectable non-small cell lung cancer…
AACR AACR 2021: Immunotherapy combination shows early promise in aggressive brain cancers April 13, 2021 Immunotherapy together with an experimental cancer drug could offer a new way of treating some…
Cancer Drug News Novel “Hydrogel” Carriers for Anti-Cancer Drugs Offer New Hope for Cancer Treatment! April 9, 2021 Hydrogels are often used as drug delivery systems, but to be effective carriers for anti-cancer…
Cancer Drug News Study finds why some cancer drugs may be ineffective April 7, 2021 A possible explanation for why many cancer drugs that kill tumour cells in mouse models…
Cancer Drug News Researchers use machine learning to rank cancer drugs in order of efficacy March 29, 2021 Researchers from Queen Mary University of London, UK, have developed a machine learning algorithm that…
Cancer Drug News Second drug targeting KRASG12C shows benefit in mutated non-small-cell lung cancer March 29, 2021 Clinical activity with a second drug inhibiting KRASG12C confirms its role as a therapeutic target…
Cancer Drug News Trackable and guided ‘nanomissiles’ deliver cancer-fighting drug straight to the tumour March 25, 2021 Researchers from Skoltech, Russia, and their colleagues from Hadassah Medical Center, Israel, have developed hybrid…
Breast Cancer Common drugs for type 2 diabetes and obesity do not increase breast cancer risk March 25, 2021 Commonly used medications for type 2 diabetes and obesity called glucagon like peptide-1 receptor agonists…
Breast Cancer Lower dose of oestrogen receptor modulator seems to reduce risk of breast cancer March 23, 2021 While the drug tamoxifen reduces the risk of developing breast cancer and prevents recurrence, the…